+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Diagnostics Market by Technology, Cancer Type, End User - Global Forecast to 2030- Product Image
Cancer Diagnostics Market by Technology, Cancer Type, End User - Global Forecast to 2030- Product Image
Sale

Cancer Diagnostics Market by Technology, Cancer Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011653
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cancer diagnostics market is experiencing rapid transformation as emerging technologies align with evolving clinical needs, offering healthcare providers new pathways for precise detection and therapy personalization. Senior decision-makers must track these shifts to sustain growth and mitigate rising operational complexities.

Market Snapshot: Cancer Diagnostics Market Overview

The Cancer Diagnostics Market grew from USD 33.31 billion in 2024 to USD 37.32 billion in 2025. It is expected to continue growing at a CAGR of 11.82%, reaching USD 65.14 billion by 2030. This acceleration is fueled by implementation of advanced methods that support earlier detection, sharper risk stratification, and more tailored therapies. As oncology care evolves, hospitals, labs, and diagnostic providers must adapt to a landscape characterized by technology convergence, regulatory evolution, and cost containment imperatives. These dynamics highlight the need for strategic resource allocation and realignment of supply chain strategies to capture incremental value and stay ahead of disruption.

Scope & Segmentation: Coverage Across Technologies, Cancer Types, and Geographies

  • Technology: Flow Cytometry, Imaging (CT, MRI, PET, Ultrasound), Immunohistochemistry (Chromogenic, Fluorescent), In Situ Hybridization (CISH, FISH), Molecular Diagnostics (Microarray, PCR, Sequencing).
  • Cancer Type: Hematological Cancers (Leukemia, Lymphoma, Multiple Myeloma), Solid Tumors (Breast, Colorectal, Lung, Prostate).
  • End User: Ambulatory Care (Oncology Clinics, Physician Offices), Diagnostic Laboratories (Hospital-based, Independent), Hospitals (General, Specialized, Tertiary), Research Institutes (Academic, Private Centers).
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, and additional countries).
  • Company Coverage: Major players include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, QIAGEN N.V., Sysmex Corporation, Illumina, Inc., bioMérieux SA, Siemens Healthineers AG, and Agilent Technologies, Inc.

Key Takeaways for Decision-Makers

  • Investment in AI and molecular profiling is redefining standards for diagnostic accuracy, making integrated analytics central to outcome-driven care.
  • Segmentation illustrates a diverse market, with demand rising across both hematological malignancies and prevalent solid tumors, supporting robust innovation pipelines.
  • Growth in decentralized testing and digital engagement is empowering smaller clinics, expanding reach beyond traditional hospital centers.
  • Strategic collaboration between biotech startups and established firms is accelerating solution development and enabling rapid market adaptation.
  • Patient-centric models are increasing requirements for interoperability, influencing both product design and data management protocols.
  • Regional market trends demand tailored strategies, as market access, reimbursement, and infrastructure maturity differ significantly across geographies.

Tariff Impact: Navigating Trade and Cost Pressures

Recent tariffs implemented in the United States have created cost headwinds for manufacturers with global supply chains, leading to shifts such as production relocation and increased dual sourcing. These upheavals ripple through procurement processes, as hospitals and labs seek greater price stability and look for alternative supply partnerships. The push for localized manufacturing and standardized protocols increases supply chain resilience, safeguarding access to essential materials and balancing cost pressures against the need for innovation continuity.

Methodology & Data Sources

This report applies a rigorous research design combining secondary data reviews—including regulatory filings, peer-reviewed articles, and industry databases—with structured interviews and targeted surveys of key industry stakeholders. Quantitative models support market forecasts, while qualitative insights are validated through triangulation with financial and operational intelligence.

Cancer Diagnostics Market: Why This Report Matters

  • Enables strategic alignment with technology, regulatory, and patient trends shaping future diagnostic care.
  • Provides actionable segmentation insights to refine R&D priorities, inform commercialization roadmaps, and support cross-border market entry.
  • Guides risk mitigation plans addressing new trade, sourcing, and pricing challenges emerging from current market conditions.

Conclusion

The cancer diagnostics market is being reshaped by a blend of technological, regulatory, and market forces. This report equips business leaders with the clarity and foresight to leverage innovation and optimize positioning in an evolving diagnostic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.2.1. Cell Sorting
8.2.2. Multiparameter Flow Cytometry
8.3. Imaging
8.3.1. Computed Tomography
8.3.2. Magnetic Resonance Imaging
8.3.3. Positron Emission Tomography
8.3.4. Ultrasound
8.4. Immunohistochemistry
8.4.1. Chromogenic
8.4.2. Fluorescent
8.5. In Situ Hybridization
8.5.1. Cish
8.5.2. Fish
8.6. Molecular Diagnostics
8.6.1. Microarray
8.6.2. Pcr
8.6.3. Sequencing
9. Cancer Diagnostics Market, by Cancer Type
9.1. Introduction
9.2. Hematological Cancers
9.2.1. Leukemia
9.2.2. Lymphoma
9.2.3. Multiple Myeloma
9.3. Solid Tumors
9.3.1. Breast Cancer
9.3.2. Colorectal Cancer
9.3.3. Lung Cancer
9.3.4. Prostate Cancer
10. Cancer Diagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Care
10.2.1. Oncology Clinics
10.2.2. Physician Offices
10.3. Diagnostic Laboratories
10.3.1. Hospital Based Laboratories
10.3.2. Independent Laboratories
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialized Cancer Centers
10.4.3. Tertiary Care Hospitals
10.5. Research Institutes
10.5.1. Academic Institutes
10.5.2. Private Research Centers
11. Americas Cancer Diagnostics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Cancer Diagnostics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Cancer Diagnostics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. F. Hoffmann-La Roche Ltd
14.3.2. Abbott Laboratories
14.3.3. Thermo Fisher Scientific Inc.
14.3.4. Danaher Corporation
14.3.5. QIAGEN N.V.
14.3.6. Sysmex Corporation
14.3.7. Illumina, Inc.
14.3.8. bioMérieux SA
14.3.9. Siemens Healthineers AG
14.3.10. Agilent Technologies, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. CANCER DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. CANCER DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 92. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 93. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 94. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 96. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 99. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 101. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 102. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 104. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 187. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 189. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 191. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 192. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 193. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 194. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 196. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 217. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 219. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 220. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 221. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 223. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 225. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 226. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 228. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 229. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 233. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 234. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 235. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 236. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 237. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 238. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 239. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 240. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 287. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 289. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 290. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 291. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 292. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 294. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 295. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 296. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 299. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 315. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 317. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 318. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 319. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 320. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 321. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 322. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2030 (USD MILLION)
TABLE 323. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 324. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, 2018-2030 (USD MILLION)
TABLE 326. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 327. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 328. QATAR CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 329. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 331. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 332. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 333. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 334. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 335. FINLAND CANCER DIAGNOSTICS MARKET SIZE, BY CANCER T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cancer Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • Sysmex Corporation
  • Illumina, Inc.
  • bioMérieux SA
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 37.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 65.14 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Head & Neck Cancer Diagnostics Market by Product Type, Technology, End User, Application, Cancer Type - Global Forecast to 2030 - Product Image

Head & Neck Cancer Diagnostics Market by Product Type, Technology, End User, Application, Cancer Type - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests, Imaging Tests, Molecular Tests), By End-use (Hospitals And Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests, Imaging Tests, Molecular Tests), By End-use (Hospitals And Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Brain Cancer Diagnostics Market by Technology, Product, Indication, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Brain Cancer Diagnostics Market by Technology, Product, Indication, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.